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Abstract 
Purpose: To evaluate the influence of Salvianolic acid B (Sal B) on oxidative stress in mice 
administrated with glucose, sucrose and high-sugar diet.  
Methods: 40 Kunming mice were divided into four groups of 10. After a fast of 12 h, mice were treated 
by oral infusion respectively with physiological saline, 20 % glucose, 20 % sucrose, and 20 % glucose + 
0.002 % Sal B. Blood glucose and levels of reactive oxygen species (ROS) were determined at 0, 0.5, 
1.0, 1.5, and 2.0 h after administration. Another 3 groups of 10 Kunming mice each were fed with 
normal diet, high-sugar diet (20 % sucrose, HSD) and HSD + 0.002 % Sal B. Four weeks later, the 
levels of ROS as well as antioxidant enzyme activity were determined. 
Results: Blood ROS showed the first peak at 0.5 h and a higher peak at 1.5 h after high glucose 
administration. ROS were mainly produced in liver and pancreas with the utilization of glucose. Sal B 
administration prevented increase in blood glucose and significantly (p < 0.05) reduced ROS produced 
in the process of glucose absorption and utilization, especially the latter. Sal B decrease oxidative stress 
induced by HSD through scavenging ROS associated with increased activity of antioxidant enzymes.  
Conclusion: This study demonstrates that Sal B can decrease oxidative stress in glucose absorption 
and utilization in HSD mice. Thus, the findings provide a basis for a potential interventional strategy for 
protecting against oxidative damage induced by HSD.  
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Oxidative stress occurs when there is an 
imbalance between the production of reactive 
oxygen species (ROS) and the scavenging ability 
of antioxidants [1]. Emerging evidence indicates 
that excessive production of ROS is an important 
factor that contributes to the pathophysiology of a 
variety of diseases. A balance between oxidant 
and antioxidant intracellular systems is hence 
vital for cell function, regulation, and adaptation 
to diverse growth conditions [2]. 
 
Hyperglycemia is a widely known cause of 
enhanced free radical concentration, which can 
generate free radicals by autoxidation and 
glycation of proteins [3]. Elevated glucose 
concentration directly injures cells and induces 
lipid peroxidation, which is the main cause for 
diabetic complications [4]. Cumulative evidence 
showed that oxidative stress, induced by reactive 
oxygen derived from hyperglycemia, caused 
abnormal gene expression, altered signal 
transduction as well as the activation of 
pathways leading to programmed myocardial cell 
deaths [5]. 
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Salvianolic acid B (Sal B), a potent anti-oxidant 
component from Salvia miltiorrhiza (SM; family: 
Labiatae), is responsible for many of Salvia 
miltiorrhiza's therapeutic actions such as the 
treatment of angina pectoris and cardiovascular 
diseases [6]. Sal B exhibits higher scavenging 
and antioxidant activities than vitamin C, and 
significantly inhibits H2O2-induced matrix 
metalloproteinases-2 (MMP-2) mRNA and 
protein expression in human aortic smooth 
muscle cells (HASMCs) [7]. 
 
Numerous studies have reported that elevated 
glucose concentration may cause oxidative 
stress, Sal B has been demonstrated to possess 
antioxidant effects. The finding that increased 
ROS production in rat mesangial cells was 
induced by glucose uptake and metabolism [8] 
has prompted us to study the effect of Sal B on 
blood glucose regulation and the formation of 
ROS in the process of glucose absorption and 
utilization. Oxidative stress is essentially resulted 
from imbalanced energy intake and expenditure 
of the body from a metabolic point of view. On 
the basis of the first experiment, we wondered 
whether Sal B would have the antioxidant effect 
in HSD mice, which were closely associated with 
many cardiovascular diseases. Thus, we 
evaluated the effect of Sal B on ROS production 






Sal B was purchased from Xi'an Honson 
Biotechnology Co., Ltd. (Xi'an, China.). It was 
originally isolated and purified from dried roots of 
S. miltiorrhiza.  
 
Experiments were conducted with male Kunming 
mice (Experimental Animal Centre to Chinese 
Academy of Science, 4 wk old, 20.92 ± 1.97 g). 
Before the study, mice in each group were fed 
initially with the normal diet for 1 week for 
adaptation. Mice were housed under conditions 
of controlled temperature (23 ± 2 °C) and 
humidity (60 %) with natural light. All 
experimental animal care and treatment followed 
the guidelines set up by the Institutional Animal 




In the first experiment, 40 mice were randomly 
divided into four groups. The mice in each group 
were administered intragastrically with 
physiological saline, 20 % (w/w) glucose, 20 % 
sucrose, and 20 % glucose + 0.002 % Sal B 400 
μl, respectively, after a fast of 12 h. Blood was 
collected from the tail vein into glass tubes with 
anticoagulant sodium heparin at 0, 0.5, 1.0, 1.5 
and 2.0 h after administration, for the 




In the second experiment, 30 mice were 
randomly and averagely divided into a control 
group (normal diet), a HSD group (20 % sucrose, 
w/w) and a HSD + Sal B group (HSD + 0.002 % 
Sal B). Animals in each group were allowed free 
access to the test diets and water for 4 weeks. 
Compositions of the animal diets are listed in 
Table 1. At the end of the experimental periods, 
mice were deprived of food for 12 h and then 
they were slightly anesthetized. Blood used for 
the measurement of ROS was collected into 
glass tubes with anticoagulant sodium heparin by 
orbital vein puncture under anesthesia, and the 
mice euthanized with an overdose of anesthetic. 
Plasma was obtained from blood samples after 
centrifugation (3000 rpm for 10 min at 4°C) and 
stored at -20°C until analysis for the antioxidant 
activity. Tissues such as liver, pancreas, 
stomach, duodenum, jejunum and ileum were 
dissected out immediately, weighed, and then 
homogenized in tissue teflon glass Dounce 
homogenizers with 50 mM physiological saline 
(pH 7.4) to obtain 10 % (w/v) whole homogenate. 
The homogenates were used for the 
determination of ROS, then they were 
centrifuged at 4000 rpm for 15 min at 4 °C to 
discard any cell debris, and the supernatant was 
used for the measurement of superoxide 
dismutase (SOD), glutathione peroxidase (GSH-
Px), catalase (CAT), and total antioxidant 
capacity (T-AOC). 
 
Measurement of ROS 
 
Levels of ROS were determined by luminol-
dependent CL measurements [9-11]. The 
reaction mixture contained 25L fresh 
anticoagulated blood or 50L 10% homogenate 
in 855 L (830 L for homogenate) Krebs-
HEPES (pH 7.4) buffer and 20L horseradish 
peroxidase (HRP) (12.4 U/ml) as a catalyst. 100 
L luminal (5 mmol/l) was added to the reaction 
mixture after the initiation of CL. 10 L of 5 
mmol/l luminol was added to 400 µL of PBS as a 
negative control. Levels of ROS were determined 
by measuring chemiluminescence in the 
integrated mode for 1 min. Results were 
expressed as x 103 counted photons per minute 
(cpm) per 1 ml blood. Data from CL experiments 
were expressed as integrated area under the 
curve. The total amount of gross ROS produced 
in each tissue of control and HSD mice was 
calculated by gross ROS = gross weight of each  
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Table 1: Composition of diet 
 
Ingredient  
(%w/w) Control HSD 
Ingredient  
(%w/w) Control HSD 
Cornmeala 42.98 21.88 Lysine 0.25 0.25 
Soybean mealb 24.0 28.24 Methionine 0.29 0.29 
Wheat flour 18.70 15.48 Choline 0.10 0.10 
Corn bran 9.0 9.0 AIN-76 Minerals 0.06 0.06 
Lardc 2.0 2.18 NaCl 0.20 0.20 
CaHPO4 1.0 1.0 AIN-76 Vitamins 0.02 0.02 
CaCO3 1.3 1.3 Sucrose 0.10 20.0 
a Cornmeal contains 9.2% protein, 73.8% carbohydrate, and 3.5% fat. b Soybean meal contains 41.5% protein, 35% 
carbohydrate, and 5% fat. c Lard provides the following (g/100 g lard): 14:0, 2.0; 14:1, 0.3; 15:1, 0.1; 16:0, 26.5; 16:1, 3.7; 17:0, 
0.5; 17:1, 0.4; 18:0, 12.1; 18:1, 42.5; 18:2(ω-6), 9.8; 18:3(ω-3), 0.7; 20:0, 0.2; 20:1, 0.6; 20:4(ω-6), 0.3. 
 
tissue (mg) × ROS level per mg (103 cpm/mg 
tissue). 
 
Estimation of blood glucose 
 
Blood glucose was measured using reagent 
strips for a LifeScan SureStep ® Flexx glucose 
meter (Johnson and Johnson, Rochester, USA).  
 
Antioxidant activity assay 
 
Total protein contents were determined by the 
method of Lowry et al [12], using bovine serum 
albumin as a standard. SOD, GSH-Px, CAT 
activities and T-AOC were measured with the 
corresponding diagnostic kits (Nanjing Jiancheng 
Bioengineering Institute, Nanjing, PR China) 




All results were expressed as mean ± standard 
deviation. Comparisons across groups were 
performed by one-way analysis of variance with 
post hoc Tukey's test. P<0.05 was considered 
statistically significant. Pearson Test was also 
employed to test the correlation between 
antioxidant capacity and the levels of reactive 
oxygen species in blood and tissues of mice. 
Analysis was done with SPSS 13.0 (SPSS, Inc, 






Effect of glucose or sucrose administration 
on ROS production and blood glucose in 
mice 
 
The ROS production of blood increased slightly 
after intragastric administration with physiological 
saline. There was no significant difference 
among different time points. The level of ROS in 
blood showed the first peak at 0.5 h after glucose 
administration, which reached the highest peak 
at 1.5 h before decline. The level of ROS in the 
glucose administrated mice was significantly (p < 
0.05) higher than that of the sucrose 
administrated mice (Fig 1 A). There was no 
significant difference in blood glucose after 
intragastric administration with physiological 
saline among different time points. Blood glucose 
after intragastric administration with glucose and 
sucrose reached their highest peak at 0.5 h, and 
the blood glucose after glucose administration 
was higher than sucrose (p < 0.05) (Fig 1 B). 
 
Effect of Sal B on ROS production and blood 
glucose in mice after oral infusion with 
glucose 
 
We found that Sal B administration did not 
change the trend of ROS and blood glucose in 
high glucose administrated mice, but reduced the 
level of ROS, especially in the utilization of 
glucose (p < 0.05) and prevented the increase of 
blood glucose (p > 0.05) (Fig 2A and B). 
 
We found that ROS production by liver and 
pancreas increased by 35 and 100 %, 
respectively, in HSD mice, compared to control 
mice (Table 2). Treatment with Sal B decreased 
ROS production in liver by 104.05 %, and in 
pancreas by 84.65 %, compared to HSD mice.  
 
Effect of Sal B on antioxidant activity of HSD 
mice 
 
SOD and GSH-Px activities were significantly (p 
< 0.05) decreased in plasma and all test tissues 
of HSD mice (Table 3). Sal B increased SOD and 
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Effects of glucose or sucrose administration on the ROS and blood glucose of mice (A, B) Glucose 
20% ( ); Sucrose 20% ( ); Physiological saline ( ). Note: Values are expressed as mean ± SD (n = 







Fig 2: Effects of Sal B on the ROS and blood glucose in mice after the oral infusion of glucose(A, B) 
Glucose 20% ( ); Glucose 20%+Sal B 0.002% ( ); Physiological saline ( ). Note: Values are 
expressed as mean ± SD (n = 10). Means in the same time with different letters significantly differ at p 
< 0.05. 
 
Table 2: Effect of Sal B on the level of ROS in blood (103 cpm/ml) and tissues 
(103 cpm/mg tissue) of control and experimental mice 
 
Tissue Control HSD HSD+Sal B 
Blood 44.1±11.4ab 53.1±19.3a 30.0±9.1b 
Liver 288.5±60.9b 515.4±158.0a 279.3±61.2b 
Pancreas 322.8±135.8c 599.1±93.5a 365.2±86.8bc 
Stomach 255.8±167.5ab 419.5±85.5a 203.4±54.6b 
Duodenum 242.3±85.0ab 305.3±94.2a 124.3±32.7c 
Jejunum 201.6±71.5a 213.4±59.2a 102.7±37.2b 
Ileum 282.8±115.6a 298.3±65.2a 219.9±18.6ab 
Note: cpm = counted photons per minute. Values are expressed as mean ± SD (n = 10). Mean 
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Table 3: Effect of Sal B on SOD and GSH-Px activities in plasma (U/ml) and tissues (U/mg protein) of 
control and experimental mice 
 
Tissue SOD  GSH-Px Control HSD HSD+Sal B Control HSD HSD+Sal B 
Plasma 3.45±0.16b 1.68±0.24c 3.79±0.52a  165.66±10.64a 144.04±3.79b 155.70±6.75ab 
Liver 60.68±2.86a 36.94±1.25c 55.68±1.33b  5.36±0.17a 3.51±0.57b 5.34±0.18a 
Pancreas 32.43±1.25a 15.97±1.34c 29.66±1.31b  17.13±1.25a 11.50±1.39b 16.91±1.40a 
Stomach 28.79±0.98a 12.39±0.60c 25.59±1.38b  6.79±0.20a 4.61±0.30b 6.70±0.19a 
Duodenum 36.07±2.13a 16.79±2.26c 31.94±1.84b  17.08±1.56a 11.83±0.77c 15.25±0.62b 
Jejunum 37.92±2.27a 17.77±1.66c 29.25±4.27b  13.66±0.30a 9.41±0.92b 13.30±0.31a 
Ileum 38.73±2.36a 16.46±1.50c 30.75±1.79b  5.79±0.32a 2.91±0.20c 4.94±0.26b 
Note: Values are expressed as mean ± SD (n=10); means with different superscript letters within a row are significantly 
different (p < 0.05). 
 
Table 4: Effect of Sal B on CAT activity and T-AOC in plasma (U/ml) and tissues (U/mg protein) of 
control and experimental mice 
Tissue CAT  T-AOC Control HSD HSD+Sal B Control HSD HSD+Sal B 
Plasma 34.64±7.18a 22.00±5.23b 30.69±2.48a  1.87±0.44a 1.25±0.17b 1.66±0.10ab 
Liver 7.81±1.23a 6.20±0.56a 7.68±0.83a  1.03±0.16a 0.62±0.12c 0.83±0.12ab 
Pancreas 14.09±1.55a 9.78±1.05b 11.97±0.58ab  4.52±0.32a 3.42±0.23b 4.21±0.41a 
Stomach 7.77±1.58a 5.46±0.96b 8.33±0.95a  0.63±0.05a 0.45±0.04b 0.59±0.06a 
Duodenum 21.38±4.60a 15.19±1.48b 17.10±1.58ab  0.80±0.07a 0.54±0.18b 0.57±0.08b 
Jejunum 16.84±2.12a 8.81±1.56c 14.52±1.94b  0.64±0.05a 0.33±0.01c 0.53±0.04b 
Ileum 11.25±0.93a 9.70±1.12b 11.49±1.23a  0.50±0.02a 0.27±0.02b 0.51±0.04a 
Note: Values are expressed as mean ± SD (n=10); means with different superscript letters within a row are significantly 
different (p < 0.05). 
 
Table 5: Pearson correlation coefficient of ROS levels and antioxidant capacity in 
blood and tissues of mice 
 
ROS SOD GSH-Px CAT T-AOC 
Plasma  -0.438+ -0.382   -0.598++ -0.387 
Liver   -0.550++   -0.903++   -0.665++   -0.706++ 
Pancreas   -0.801++   -0.904++   -0.813++   -0.910++ 
Stomach   -0.534++   -0.671++   -0.787++   -0.735++ 
Duodenum  -0.412+ -0.427 -0.252 -0.157 
Jejunum -0.281  -0.485+  -0.407+ -0.321 
Ileum -0.240 -0.133   -0.632++  -0.421+ 




Effect of Sal B on ROS production of HSD 
mice 
 
There was a significant (p < 0.05) decrease in 
CAT activity in all tissues of HSD mice except for 
liver (Table 4). Sal B treatment significantly 
inhibited the decrease in CAT activity in all 
tissues except for liver, pancreas and duodenum. 
Treatment of HSD mice also showed a marked 
decrease in T-AOC in plasma and all tissues 
(Table 4). Administration of Sal B greatly 
elevated T-AOC in all tissues of HSD group 




As was shown by correlation assay (Table 5), 
there was a negative correlation between the 
production of ROS and the activities of 
antioxidant enzymes, especially in liver and 
pancreas. The level of ROS correlated negatively 
with T-AOC (liver and pancreas) where r= -





Acute hyperglycaemia can impair the 
physiological homeostasis of important systems 
in living organisms and may exert these effects 
via the production of free radicals and associated 
oxidative stress [13]. Ha & Lee [8] reported 
increased ROS production in rat mesangial cells 
within 15 min of incubation in 30 mM D-glucose. 
This increase in production was prevented by 
inhibiting glucose transport into the cells, and no 
effect of 25 mM L-glucose or the 
nonmetabolizing analogue 3-O-methyl-d-glucose 
was seen, implying that glucose uptake and 
metabolism triggered the response seen.  
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In our study, blood ROS increased slightly after 
oral infusion of physiological saline. There was 
no significant difference among different time 
points, suggesting that the release of reactive 
oxygen species was not affected by the course of 
oral administration. No significant difference of 
blood glucose was seen among different time 
points after oral infusion with physiological saline. 
Blood glucose rose rapidly 0.5 h after glucose 
infusion. Glucose intake could be said to be the 
main course of glucose absorption and 
appearance of the first ROS release peak, 
suggesting that a large amount of ROS were 
produced during the absorption of glucose. Blood 
glucose declined with the use of glucose by 
tissues and cells, which correlates with the 
second higher peak of ROS at time 1.5h, 
showing that more ROS were produced during 
glucose utilization. This is consistent with a 
previous study [8] in which cytochalasin B, an 
inhibitor of glucose transporter, effectively inhibits 
high glucose-induced ROS generation and 
suggests that glucose uptake and metabolism 
are required in high glucose-induced cytosolic 
ROS generation.  
 
The effect of oral infusion with sucrose showed 
similar trend to that of glucose but with lower 
peak, suggesting that more ROS were produced 
in the absorption and utilization of glucose than 
sucrose. Sucrose is decomposed into the same 
mole of glucose and fructose in vivo before 
absorption under the role of sucrase, which may 
be the reason for the lower blood glucose peak 
compared to glucose administration. 
 
It has been reported that ROS production is 
triggered by acute elevation of plasma glucose 
[14]. Elevated glucose causes increased 
superoxide production [15]. Sal B is composed of 
three danshensu units (chemical name D-(+) β-
(3, 4-dihydroxyphenyl) lactic acid) and one 
caffeic acid unit through ester linkage and 
condensation at the aromatic ring of caffeic acid. 
Caffeic acid and its various oligomers were 
shown to possess different antioxidant activities. 
Danshensu, a monomer of caffeic acid, is the 
hydrated form of caffeic acid in Salvia 
miltiorrhiza. It was shown that condensation and 
conjugation of caffeic acid and its derivatives 
appeared to be important for antioxidant activity. 
Indeed Sal B has been demonstrated to protect 
hepatocytes against oxidative injury including 
lipid peroxidation and ROS formation [16]. Sal B 
decreases ROS production and NADPH oxidase 
activity induced by TNF-α in a dose-dependent 
manner [7]. In our study, high glucose infusion 
induced oxidative stress, while treatment with 
0.002 % Sal B showed a considerable decrease 
in blood glucose, and a significantly reduction of 
ROS production especially in the course of 
glucose absorption and utilization. Decrease in 
oxidative stress of diabetic subjects is mediated 
by improved glycemic control [17]. The 
implication is that the glucose control effect of 
Sal B is significantly associated with the release 
of associated oxidative stress.  
 
Hyperglycemia is a widely known cause of 
enhanced free radical concentration. Similar to a 
previous study [18], the HSD resulted in 
significant increase in ROS in our experiments, 
suggesting that the high-sugar diet evoked 
oxidative stress. ROS levels in liver and 
pancreas were higher compared to other tissues, 
which points to the important role of liver and 
pancreas in glucose metabolism. Liver produced 
the largest amount of ROS among all the tissues 
which is consistent with the findings of a previous 
study that more ROS are produced in the course 
of glucose utilization. The fact that Sal B 
treatment decreased ROS production indicates 
that it can relieve the associated oxidative stress, 
especially in the course of glucose utilization. 
 
As free radical scavengers, SOD, GSH-Px and 
CAT exist in all oxygen-metabolizing cells, 
preventing cells from damage by free radicals, 
but their activities are significantly reduced in 
many oxidative stress injuries [19,20]. In the 
present study, HSD resulted in significant 
oxidative damage to plasma and tissues, as 
characterized by decreased SOD, GSH-Px and 
CAT activities in HSD mice. The activities of the 
antioxidant enzymes correlated negatively with 
the level of ROS in the present work, suggesting 
that the overproduction of ROS was significantly 
associated with the decrease of antioxidant 
enzymes. Sal B is reported to possess 
antioxidant hepatoprotective and antifibrogenic 
effects [16]. In the present study, Sal B treatment 
released the associated oxidative stress by 
eliminating ROS as well as increasing the 
activities of antioxidant enzymes. T-AOC reflects 
the capacity of non-enzymatic antioxidant 
defense system. Sal B treatment also increased 
T-AOC, suggesting that an enhanced antioxidant 
defense mechanism suppressed peroxidation in 




The present study demonstrates that Sal B can 
considerably decrease blood glucose and ROS 
produced during the absorption and utilization of 
glucose, especially the latter. Administration of 
Sal B alleviates oxidative stress induced by HSD 
by decreasing the production of ROS and 
increasing antioxidant enzymes, suggesting that 
Wang et  al 
Trop J Pharm Res 2014;13(3): 375  
 
Sal B has potential to act as natural antioxidants 
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